Cloud-clone
SKU:LME112Hu
Magnetic Luminex Assay Kit for Ephrin B2 (EFNB2) ,etc.
Magnetic Luminex Assay Kit for Ephrin B2 (EFNB2) ,etc.
Couldn't load pickup availability
Product No.
LME112Hu
Organism Species
Homo sapiens (Human).
Sample Type
Tissue homogenates, cell lysates, cell culture supernates and other biological fluids
Test Method
Double-antibody Sandwich
Assay Length
3.5h
Detection Range
0.01-10ng/mL
Sensitivity
The minimum detectable dose of this kit is typically less than 0.003 ng/mL.
UOM
1Plex 2Plex 3Plex 4Plex 5Plex 6Plex 7Plex 8Plex
Specificity
This assay has high sensitivity and excellent specificity for detection of Ephrin B2 (EFNB2) ,etc..
No significant cross-reactivity or interference between Ephrin B2 (EFNB2) ,etc. and analogues was observed.
Recovery
Matrices listed below were spiked with certain level of recombinant Ephrin B2 (EFNB2) ,etc. and the recovery rates were calculated by comparing the measured value to the expected amount of Ephrin B2 (EFNB2) ,etc. in samples.
| Matrix | Recovery range (%) | Average(%) |
| serum(n=5) | 89-98 | 93 |
| EDTA plasma(n=5) | 93-101 | 96 |
| heparin plasma(n=5) | 78-88 | 81 |
| sodium citrate plasma(n=5) | 80-92 | 88 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Ephrin B2 (EFNB2) ,etc. were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Ephrin B2 (EFNB2) ,etc. were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Ephrin B2 (EFNB2) ,etc. and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
| Sample | 1:2 | 1:4 | 1:8 | 1:16 |
| serum(n=5) | 93-101% | 94-103% | 78-103% | 80-89% |
| EDTA plasma(n=5) | 91-101% | 94-105% | 86-94% | 93-101% |
| heparin plasma(n=5) | 86-101% | 90-104% | 94-101% | 87-102% |
| sodium citrate plasma(n=5) | 79-97% | 78-101% | 79-92% | 88-96% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
| Reagents | Quantity | Reagents | Quantity |
| 96-well plate | 1 | Plate sealer for 96 wells | 4 |
| Pre-Mixed Standard | 2 | Standard Diluent | 1×20mL |
| Pre-Mixed Magnetic beads (22#:EFNB2) | 1 | Analysis buffer | 1×20mL |
| Pre-Mixed Detection Reagent A | 1×120μL | Assay Diluent A | 1×12mL |
| Detection Reagent B (PE-SA) | 1×120μL | Assay Diluent B | 1×12mL |
| Sheath Fluid | 1×10mL | Wash Buffer (30 × concentrate) | 1×20mL |
| Instruction manual | 1 |
Assay procedure summary
1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.
| Magazine | Citations |
| ATS Journals | Soluble Ephrin-B2 is a Novel Biomarker for Idiopathic Pulmonary Fibrosis Doi: Pdf |
| D50. PEDIATRIC RARE LUNG DISEASES | Soluble Ephrin-B2 Is A Novel Biomarker Of Pulmonary Fibrosis doi:A7217 |
| An International Journal of Medicine | P055 Over-expression of IL-6 and OSM impacts the polarization of pro-fibrotic macrophages and the development of bleomycin-induced lung fibrosis content:109 |
| An International Journal of Medicine | P057 Soluble Ephrin-B2 is a Prognostic Biomarker of Pulmonary Fibrosis S40.2.extract |
| 4 | ADAM10-mediated ephrin-B2 shedding promotes myofibroblast activation and organ fibrosis pubmed:29058717 |
| Catalog No. | Related products for research use of Homo sapiens (Human) Organism species | Applications (RESEARCH USE ONLY!) |
| RPE112Hu02 | Recombinant Ephrin B2 (EFNB2) | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPE112Hu01 | Recombinant Ephrin B2 (EFNB2) | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAE112Hu01 | Polyclonal Antibody to Ephrin B2 (EFNB2) | WB; IHC; ICC; IP. |
| MAE112Hu21 | Monoclonal Antibody to Ephrin B2 (EFNB2) | WB; IHC; ICC; IP. |
| SEE112Hu | ELISA Kit for Ephrin B2 (EFNB2) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LME112Hu | Magnetic Luminex Assay Kit for Ephrin B2 (EFNB2) ,etc. | Magnetic Luminex Assay for Antigen Detection. |
Share
